111 related articles for article (PubMed ID: 18182238)
1. Protective actions of human tissue kallikrein gene in transgenic rat hearts.
Silva JA; Silva MR; Nascimento JW; Bader M; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):267-70. PubMed ID: 18182238
[TBL] [Abstract][Full Text] [Related]
2. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene.
Silva JA; Araujo RC; Baltatu O; Oliveira SM; Tschöpe C; Fink E; Hoffmann S; Plehm R; Chai KX; Chao L; Chao J; Ganten D; Pesquero JB; Bader M
FASEB J; 2000 Oct; 14(13):1858-60. PubMed ID: 11023967
[TBL] [Abstract][Full Text] [Related]
3. Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.
Koch M; Spillmann F; Dendorfer A; Westermann D; Altmann C; Sahabi M; Linthout SV; Bader M; Walther T; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2006 Nov; 550(1-3):143-8. PubMed ID: 17022964
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.
Tschöpe C; Walther T; Königer J; Spillmann F; Westermann D; Escher F; Pauschinger M; Pesquero JB; Bader M; Schultheiss HP; Noutsias M
FASEB J; 2004 May; 18(7):828-35. PubMed ID: 15117887
[TBL] [Abstract][Full Text] [Related]
5. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
Chao J; Bledsoe G; Yin H; Chao L
Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-kinin in stroke, cardiovascular and renal disease.
Chao J; Chao L
Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
[TBL] [Abstract][Full Text] [Related]
7. Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene.
Passaglio KT; Baltatu O; Machado RP; dos Reis AM; Pesquero JB; Bader M; Santos RA
Regul Pept; 2005 Jan; 124(1-3):127-35. PubMed ID: 15544850
[TBL] [Abstract][Full Text] [Related]
8. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
9. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
Yao YY; Yin H; Shen B; Chao L; Chao J
J Card Fail; 2007 Sep; 13(7):588-96. PubMed ID: 17826650
[TBL] [Abstract][Full Text] [Related]
10. Increased kallikrein expression protects against cardiac ischemia.
Pinto YM; Bader M; Pesquero JB; Tschöpe C; Scholtens E; van Gilst WH; Buikema H
FASEB J; 2000 Oct; 14(13):1861-3. PubMed ID: 11023968
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein gene 'knock-down' by small interfering RNA transfection induces a profibrotic phenotype in rat mesangial cells.
Pawluczyk IZ; Tan EK; Lodwick D; Harris K
J Hypertens; 2008 Jan; 26(1):93-101. PubMed ID: 18090545
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats.
Tian XL; Pinto YM; Costerousse O; Franz WM; Lippoldt A; Hoffmann S; Unger T; Paul M
Hum Mol Genet; 2004 Jul; 13(14):1441-50. PubMed ID: 15128700
[TBL] [Abstract][Full Text] [Related]
13. Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system.
Ribeiro JM; Santos RA; Pesquero JB; Bader M; Krieger EM
Regul Pept; 2005 Jul; 129(1-3):155-9. PubMed ID: 15927711
[TBL] [Abstract][Full Text] [Related]
14. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
15. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
[TBL] [Abstract][Full Text] [Related]
16. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
[TBL] [Abstract][Full Text] [Related]
17. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.
Chao J; Shen B; Gao L; Xia CF; Bledsoe G; Chao L
Biol Chem; 2010 Apr; 391(4):345-55. PubMed ID: 20180644
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
19. Reduced corporal fibrosis to protect erectile function by inhibiting the Rho-kinase/LIM-kinase/cofilin pathway in the aged transgenic rat harboring human tissue kallikrein 1.
Cui K; Luan Y; Wang T; Zhuan L; Rao K; Wang SG; Ye ZQ; Liu JH; Wang DW
Asian J Androl; 2017; 19(1):67-72. PubMed ID: 27678468
[TBL] [Abstract][Full Text] [Related]
20. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Pizard A; Richer C; Bouby N; Picard N; Meneton P; Azizi M; Alhenc-Gelas F
Biol Chem; 2008 Jun; 389(6):701-6. PubMed ID: 18627303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
